Effects of Curcurma cotnosa Roxb. On platelet aggregation and atherosclerotic plaque development in hypercholesterolemic rabbits

International Journal of Pharmacology

Volumn 8, Issue 4, 2012, Pages 234-242

  Ratanachamnong, P ^a   Matsathit, U ^b   Sanvarinda, Y ^a   Piyachaturawat, P ^a   Phivthong Ngam, L ^b  

^a Mahidol University   (Thailand)

^b SRINAKHARINWIROT UNIVERSITY   (Thailand)

Author keywords

Atherosclerosis; Curcuma comosa; Hypercholesterolemia; Platelet aggregation; Therapeutic potential

Indexed keywords

ACETYLCHOLINE; ADENOSINE DIPHOSPHATE; CHOLESTEROL; CURCUMA COMOSA EXTRACT; HYPOCHOLESTEROLEMIC AGENT; LIPID; NITROPRUSSIDE SODIUM; PLANT EXTRACT; SIMVASTATIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA ATHEROSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CURCUMA; CURCUMA COMOSA; EX VIVO STUDY; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MALE; NONHUMAN; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 84859074698     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2012.234.242     Document Type: Article

References (52)

1. Abdelhalim, M.A.K. and H.A. Alhadlaq, 2008. Effects of cholesterol feeding periods on blood haematology and biochemistry of rabbits. Int. J. Biol. Chem., 2: 49-53.
2. Alfon, J., J.F. Guasch, M. Berrozpe and L. Badimon, 1999. Nitric oxide synthase II (TSTOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors. Atherosclerosis, 145: 325-331.
3. Anand, V Chenniappan., Uma, Saravanan and S. Kumar, 2008. Redeeming measure of atorvastatin in the risk factors of cardiovascular disease. Int. J. Pharmacol., 4: 305-309.
4. Andrews, H.E., J.W. Aitken, D.G. Hassall, V.O. Skinner and K.R. Bruckdorfer, 1987. Intracellular mechanisms in the activations of human platelets by low-density lipoproteins. Biochem. J., 242: 559-564.
5. Antithrombotic Trialists' Collaboration, 2002. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ.,324: 71-86.
6. Bernini, F., G. Didoni, G. Bonfadini, S. Bellosta and R. Fumagalli, 1993. Requirement for mevalonate in acetylated LDL induction of cholesterol esterification in macrophages. Atherosclerosis, 104: 19-26.
7. Bode-Boger, S.M., R.H. Boger, S. Kienke, M. Bohme, L. Phivthong-Ngam, D. Tsikas and J.C. Frolich, 1998. Chronic dietary supplementation with L-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivo. Cardiovasc. Res., 37: 756-764.
8. Born, G.V.R., 1962. Quantitative investigation into the aggregation of blood platelets. J. Physiol., 162: 67-68.
9. CAPRIE Steering Committee, 1996. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet, 348: 1329-1339.
10. Charoenteeraboon, J., K. Nithipatikom, W.B. Campbell, P. Piyachaturawat, P. Wilairat and P. Rongnoparut, 2005. Induction of human cholesterol 7 alpha-hydroxylase in HepG2 cells by 2,4,6-trihydroxyacetophenone. Eur. J. Pharmacol., 515: 43-46.
11. Chumark, P., P. Khunawat, Y. Sanvarinda, S. Phornchirasilp and N.P. Morales et al, 2008. The in vitro and ex vivo antioxidant properties, hypolipidaemic and antiatherosclerotic activities of water extract of Moringa oleifera Lam. leaves. J. Ethnopharmacology, 116: 439-446.
12. Creager, M.A., S.J. Gallagher, X.J. Girerd, S.M. Coleman, V.J. Dzau and J.P. Cooke, 1992. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J. Clin. Invest, 90: 1248-1253.
13. Fateh-Moghadam, S., Z. Li, S. Ersel, T. Reuter and P. Htun et al, 2005. Platelet degranulation is associated with progression of intima-media thickness of the common carotid artery in patients with diabetes mellitus type 2. Arterioscler. Thromb. Vase. Biol, 25: 1299-1303.
14. Ferrom, P., S. Basih, A. Falco and G. Davi, 2004. Antioxidants and redox signaling. Antioxid Redox Signal, 6: 747-756.
15. Fisher, L.D. and G. vanBelle, 1993. Multiple Comparisons. In: Biostatistics. A Methodology for the Health Sciences, Fisher L.D. andG. vanBelle (Eds.). Wiley, New York, pp: 596-629.
16. Freedman, J.E., J. Loscalzo, M.R. Barnard, C. Alpert, J.F. Keaney and A.D. Michelson, 1997. Nitric oxide released from activated platelets inhibits platelet recruitment. J. Clin. Invest., 100: 350-356.
17. Garelnabi, M., 2010. Emerging evidences from the contribution of the traditional and new risk factors to the atherosclerosis pathogenesis. J. Med. Sci., 10: 153-161.
18. Hermann, A., B.H. Rauch, M. Braun, K. Schror and A.A. Weber, 2001. Platelet CD40 hgand (CD40L)-subcellular localization, regulation of expression and inhibition by clopidogrel. Platelets, 12: 74-82.
19. Intapad, S., A. Suksamrarn and P. Piyachaturawat, 2009. Enhancement of vascular relaxation in rat aorta by phytoestrogens from Curcuma comosa Roxb. Vase. Pharmacol, 51: 284-290.
20. Jennings, L.K., 2009. Role of platelets in atherothrombosis. Am. J. Cardiol, 103: 4A-10A.
21. Koh, K.K., C. Cardillo, M.N. Bui, L. Hathaway and G. Csako et al., 1999. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women. Circulation, 99: 354-360.
22. Kooy, M.V.M., J.W.N. Akkerman, S. van Asbeck, L. Borghms and H.C. van Prooyen, 1993. UVB radiation exposes fibrinogen binding sites on platelets by activating protein kinase C via reactive oxygen species. Br. J. Haematol, 83: 253-258.
23. Laufs, U., V. La Fata and J.K. Liao, 1997. Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J. Biol. Chem., 272: 31725-31729.
24. Lee, Y.M., W.F. Chen, D.S. Chou, T. Jayakumar and S.Y. Hou et al, 2010. Cyclic nucleotides and mitogen-activated protein kinases: Regulation of simvastatin in platelet activation. J. Biomed. Sci., 17: 45-54.
25. Lokhande, P.D., B.S. Kuchekar, A.R. Chabukswar and S.C. Jagdale, 2006. Nitric oxide: Role in biological system. Asian J. Biochem., 1: 1-17.
26. Mendelsohn, M.E. and R.H. Karas, 1999. Mechanisms of disease: The protective effects of estrogen on the cardiovascular system. N. Eng. J. Med., 340: 1801-1811.
27. Miller, M.E., G.M. Dores, S.L. Thorpe and W.L. Akerley, 1994. Paradoxical influence of estrogenic hormones on platelet-endothelial cell interactions. Thromb. Res., 74: 577-594.
28. Miller, V.T., J. LaRosa, V. Barnabei, C. Kessler and G. Levin et al., 1995. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA, 273: 199-208.
29. Nakano, Y., T. Oshima, H. Matsuura, G. Kajiyama and M. Kambe, 1998. Effect of 17-beta estradiol on inhibition of platelet aggregation in vitro is mediated by an increase in NO synthesis. Arterioscler. Thromb. Vase. Biol, 18: 961-967.
30. Niumsakul, S., A. Hirunsaree, S. Wattanapitayakul, N. Junsuwanitch and K. Prapanupun, 2007. An antioxidative and cytotoxic substance extracted from Curcuma comosa Roxb. J. Thai. Trad. Altern. Med., 5: 24-29.
31. Nurulhuda, M.H., A. Azlan, A. Ismail, Z. Amom and F.H. Shakirin, 2012. Cholesterol-lowering and artherosclerosis inhibitory effect of Sibu olive in cholesterol fed-rabbit. Asian. J. Biochem., Vol. 7, (In Press).
32. Ogbuewu, LP., A.A. Omede, O.K. Chukwuka, O.O.M. Iheshmlor and M.C. Uchegbu et al, 2010. The overview of the chemistry, health benefits and the potential threats associated with prolonged exposure to dietary soy isoflavones. Int. J. Agric. Res., 5: 1-16.
33. Phivthong-Ngam, L., S.M. Bode-Boger, R.H. Boger, M. Bohme, R.P. Brandes, A. Mugge and J.C. Frolich, 1998. Dietary L-arginine normalizes endothelin-induced vascular contractions in cholesterol-fed rabbits. J. Cardiovasc. Pharmacol., 32: 300-307.
34. Pitsilos, S., J. Hunt, E.R. Mohler, A.M. Prabhakar and M. Ponczx et al, 2003. Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thromb. Haemost.,90: 1112-1120.
35. Piyachaturawat, P., J. Charoenpiboonsin, C. Toskulkao and A. Suksamrarn, 1999. Reduction of plasma cholesterol by Curcuma comosa extract in hypercholesterolaemic hamsters. J. EthnopharmacoL, 66: 199-204.
36. Piyachaturawat, P., C. Tubtim, A. Chuncharunee, P. Komaratat and A. Suksamrarn, 2002a. Evaluation of the acute and subacute toxicity of a choleretic phloracetophenone in experimental animals. Toxicol. Lett, 129: 123-132.
37. Piyachaturawat, P., P. Srivoraphan, A. Chuancharunee, P. Komaratat and A. Suksamran, 2002b. Cholesterol lowering effects of a choleretic phloracetophenone in hypercholesterolemic hamsters. Eur. J. Pharmacol., 439: 141-147.
38. Prasanna, G. S. and A. Purnima, 2011. Protective effect of leaf extract of Trichilia connaroides on hypercholesterolemia induced oxidative stress. Int. J. Pharmacol, 7: 106-112.
39. Relou, I.A., CM. Hackeng, J.W. Akkerman and E. Malle, 2003. Low-density lipoprotein and its effect on human blood platelets. Cell. Mol. Life. Sci., 60: 961-971.
40. Rosenson, R.S. and C.C. Tangney, 1998. Antiatherothrombotic properties of statins: Implications for cardiovascular event reduction. JAMA, 279: 1643-1650.
41. Saeed, S.A., M.Z.S. Urfy, F.W.A. Khimani and S.O. Saeed, 2004. From evolution of platelets to their role in heart attacks. J. Med. Sci., 4: 47-51.
42. Sase, K. and T. Michel, 1995. Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci., 57: 2049-2055.
43. Shetty, J.K., M. Prakash, S. Tripathy, M. Verma and P. Vikram, 2008. Effect of atorvastatin on paraoxonase activity in-patients with hyperlipidemia. Asian J. Biochem., 3: 139-142.
44. Sodsai, A., P. Piyachaturawat, S. Sophasan, A. Suksamrarn and M. Vongsakul, 2007. Suppression by Curcuma comosa Roxb. Of pro-inflammatory cytokine secretion in phorbol-12-myristate-l 3-acetate stimulated human mononuclear cells. Int. Immunopharmacol., 7: 524-533.
45. Srisawat, S., L. Phivthong-Ngam, S. Unchern, U. Chantharaksri, P. Govitrapong and Y. Sanvarinda, 2003. Improvement of vascular function by chronic administration of a cyclo-oxygenase inhibitor in cholesterol-fedrabbits. Clin. Exp. Pharmacol. Physiol., 30: 405-412.
46. Sudano, I., L.E. Spieker, F. Hermann, A. Flammer and R. Corti et al., 2006. Protection of endothelial function: Targets for nutritional and pharmacological interventions. J. Cardiovasc. Pharmacol, 47: S136-S150.
47. Superko, H.R. and S. King, 2008. Lipid management to reduce cardiovascular risk: A new strategy is required. Circulation, 117: 560-568.
48. Theilmeier, G., C. Michiels, E. Spaepen, I. Vreys and D. Collen et al, 2002. Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia. Blood, 99: 4486-4493.
49. Undas, A., K.E. Brummel, J. Musial, K.G. Mann and A. Szczeklik, 2001. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V and factor XIII and by enhancing factor Va inactivation. Circulation, 103: 2248-2253.
50. Van Wilhgen, G., G. Gorter and J.W. Akkerman, 1994. LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules. Arterioscler. Thromb., 14: 41-46.
51. Vera, R, M. Sanchez, M. Galisteo, I.C. Villar and R. Jimenez et al, 2007. Chronic dysfunction in spontaneously hypertensive rats: involvement of eNOS, caveolin and calmodulin expression and NADPH oxidase activity. Clin Sci.,112: 183-191.
52. Wolf, A., C. Zalpour, G. Theilmeier, B.Y. Wang and A. Ma et al, 1997. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J. Am. Coll. Cardiol, 29: 479-485.